Clinical trial
Clinical Study of Ixabepilone Administered as a 24 Hour Infusion in Patients…
NCT00162136 · R-Pharm, Industry · Completed
Key facts
| NCT number | NCT00162136 |
|---|---|
| Title | Clinical Study of Ixabepilone Administered as a 24 Hour Infusion in Patients With Solid Malignancies. |
| Official title | Phase I Study of Ixabepilone Administered as a 24-Hour Infusion in Patients With Advanced Solid Malignancies |
| Lead sponsor | R-Pharm, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Solid Malignancies |
| Intervention type | Drug |
| Interventions | Ixabepilone |
| Enrollment | 35 |
| Start date | Sep 1, 2005 |
| Primary completion | Jul 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Sep 13, 2005 |
| Last update posted | Nov 2, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: